Literature DB >> 2118552

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency.

S Yamashita1, D L Sprecher, N Sakai, Y Matsuzawa, S Tarui, D Y Hui.   

Abstract

This study characterized the plasma lipoproteins of familial hyperalphalipoproteinemic patients with or without deficiency of cholesteryl ester transfer protein (CETP) activity. The subjects with CETP deficiency have increased levels of apolipoprotein (apo) E. The increased concentration of apo E in these subjects was correlated to the appearance of apo E-rich high density lipoproteins (HDL). Sodium dodecyl sulfate-polyacrylamide gel analysis revealed that these lipoproteins contained predominantly the apo E (82%) and little amount of apo A-I (18%). These apo E-rich HDL displayed a much higher affinity than human LDL in binding to LDL receptors on human fibroblasts. Furthermore, 3.5 times fewer apo E-rich HDL than LDL were required to saturate the receptors on fibroblasts. These data indicated that the apo E-rich HDL in CETP-deficient human subjects contained multiple copies of apo E and bound to the LDL receptor through multiple interactions. The apo E-rich HDL, with similar properties as cholesterol-induced apo E HDLc, were not detectable in normal human subjects or in hyperalphalipoproteinemic subjects with normal CETP activity. The apo E-containing HDL in the latter subjects were smaller and contained only small amounts of apo E (14%). The difference in apo E-containing HDL in these subjects suggests a correlation between CETP level and the appearance of apo E-rich HDL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118552      PMCID: PMC296782          DOI: 10.1172/JCI114764

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Rate and equilibrium constants for binding of apo-E HDLc (a cholesterol-induced lipoprotein) and low density lipoproteins to human fibroblasts: evidence for multiple receptor binding of apo-E HDLc.

Authors:  R E Pitas; T L Innerarity; K S Arnold; R W Mahley
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

3.  Very low density lipoproteins in cord blood.

Authors:  L A Carlson; L I Hardell
Journal:  Clin Chim Acta       Date:  1978-12-15       Impact factor: 3.786

4.  Cholesteryl ester exchange protein in human plasma isolation and characterization.

Authors:  N M Pattnaik; A Montes; L B Hughes; D B Zilversmit
Journal:  Biochim Biophys Acta       Date:  1978-09-28

5.  An electrophoretic method for the quantitative isolation of human and swine plasma lipoproteins.

Authors:  R W Mahley; K H Weisgraber
Journal:  Biochemistry       Date:  1974-04-23       Impact factor: 3.162

6.  Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease.

Authors:  G J Miller; N E Miller
Journal:  Lancet       Date:  1975-01-04       Impact factor: 79.321

7.  Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein.

Authors:  R E Pitas; T L Innerarity; R W Mahley
Journal:  J Biol Chem       Date:  1980-06-10       Impact factor: 5.157

8.  Canine hyperlipoproteinemia and atherosclerosis. Accumulation of lipid by aortic medial cells in vivo and in vitro.

Authors:  R W Mahley; T L Innerarity; K H Weisgraber; D L Fry
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

9.  Alterations in human high-density lipoproteins, with or without increased plasma-cholesterol, induced by diets high in cholesterol.

Authors:  R W Mahley; T L Innerarity; T P Bersot; A Lipson; S Margolis
Journal:  Lancet       Date:  1978-10-14       Impact factor: 79.321

10.  Longevity syndromes: familial hypobeta and familial hyperalpha lipoproteinemia.

Authors:  C J Glueck; P Gartside; R W Fallat; J Sielski; P M Steiner
Journal:  J Lab Clin Med       Date:  1976-12
View more
  26 in total

1.  An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels.

Authors:  T Hayek; T Chajek-Shaul; A Walsh; L B Agellon; P Moulin; A R Tall; J L Breslow
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

2.  FoxO transcription factors are required for hepatic HDL cholesterol clearance.

Authors:  Samuel X Lee; Markus Heine; Christian Schlein; Rajasekhar Ramakrishnan; Jing Liu; Gabriella Belnavis; Ido Haimi; Alexander W Fischer; Henry N Ginsberg; Joerg Heeren; Franz Rinninger; Rebecca A Haeusler
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

3.  Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.

Authors:  Jifeng Zhang; Manabu Niimi; Dongshan Yang; Jingyan Liang; Jie Xu; Tokuhide Kimura; Anna V Mathew; Yanhong Guo; Yanbo Fan; Tianqing Zhu; Jun Song; Rose Ackermann; Yui Koike; Anna Schwendeman; Liangxue Lai; Subramaniam Pennathur; Minerva Garcia-Barrio; Jianglin Fan; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-04-20       Impact factor: 8.311

4.  Cholesterol efflux potential and antiinflammatory properties of high-density lipoprotein after treatment with niacin or anacetrapib.

Authors:  Laurent Yvan-Charvet; Jelena Kling; Tamara Pagler; Hongna Li; Brian Hubbard; Tim Fisher; Carl P Sparrow; Andrew K Taggart; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-06       Impact factor: 8.311

5.  Function of cholesteryl ester transfer protein in reverse cholesterol transport.

Authors:  R McPherson
Journal:  CMAJ       Date:  1993-06-15       Impact factor: 8.262

6.  The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance.

Authors:  Melinde Wijers; Paolo Zanoni; Nalan Liv; Dyonne Y Vos; Michelle Y Jäckstein; Marieke Smit; Sanne Wilbrink; Justina C Wolters; Ydwine T van der Veen; Nicolette Huijkman; Daphne Dekker; Niels Kloosterhuis; Theo H van Dijk; Daniel D Billadeau; Folkert Kuipers; Judith Klumperman; Arnold von Eckardstein; Jan Albert Kuivenhoven; Bart van de Sluis
Journal:  JCI Insight       Date:  2019-06-06

Review 7.  Inhibition of cholesteryl ester transfer protein activity: a new therapeutic approach to raising high-density lipoprotein.

Authors:  Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

8.  A missense mutation in the cholesteryl ester transfer protein gene with possible dominant effects on plasma high density lipoproteins.

Authors:  K Takahashi; X C Jiang; N Sakai; S Yamashita; K Hirano; H Bujo; H Yamazaki; J Kusunoki; T Miura; P Kussie
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

9.  Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.

Authors:  K Ikewaki; D J Rader; T Sakamoto; M Nishiwaki; N Wakimoto; J R Schaefer; T Ishikawa; T Fairwell; L A Zech; H Nakamura
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

10.  High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.

Authors:  K J Lackner; H Dieplinger; G Nowicka; G Schmitz
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.